Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.09
-1.36 (-9.41%)
At close: Dec 18, 2024, 4:00 PM
13.00
-0.09 (-0.69%)
Pre-market: Dec 19, 2024, 4:36 AM EST
Wave Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -142.52 | -57.51 | -161.82 | -122.25 | -149.91 | -193.64 | |
| Depreciation & Amortization | 8.69 | 9.21 | 10.11 | 9.84 | 9.98 | 9.2 | |
| Loss (Gain) From Sale of Assets | - | - | 0.01 | - | - | - | |
| Stock-Based Compensation | 12.25 | 9.8 | 17.19 | 16.41 | 14.3 | 19.51 | |
| Change in Accounts Receivable | 7 | -21.09 | - | 30 | 20 | 10 | |
| Change in Accounts Payable | 0.15 | -3.76 | 9.35 | -6.57 | 5.12 | -3.5 | |
| Change in Unearned Revenue | -19.23 | 54.33 | -3.25 | -18.46 | -20.08 | -15.98 | |
| Change in Other Net Operating Assets | -6.96 | -10.4 | 0.62 | 2.04 | 4.61 | -13.82 | |
| Operating Cash Flow | -140.62 | -19.43 | -127.78 | -88.99 | -115.98 | -188.23 | |
| Capital Expenditures | -1.21 | -1.12 | -1.36 | -0.56 | -1.34 | -3.92 | |
| Sale of Property, Plant & Equipment | - | - | 0.11 | - | - | - | |
| Investing Cash Flow | -1.21 | -1.12 | -1.26 | -0.56 | -1.34 | -3.92 | |
| Issuance of Common Stock | 298.77 | 132.53 | 52.92 | 55.83 | 154.54 | 164.4 | |
| Other Financing Activities | 14.1 | - | 14.27 | - | - | - | |
| Financing Cash Flow | 312.87 | 132.53 | 67.19 | 55.83 | 154.54 | 164.4 | |
| Foreign Exchange Rate Adjustments | 0.02 | -0.1 | -0.21 | -0.21 | 0.12 | 0.11 | |
| Net Cash Flow | 171.07 | 111.89 | -62.06 | -33.93 | 37.34 | -27.64 | |
| Free Cash Flow | -141.83 | -20.55 | -129.14 | -89.55 | -117.32 | -192.15 | |
| Free Cash Flow Margin | -264.55% | -18.13% | -3539.11% | -218.61% | -584.35% | -1202.21% | |
| Free Cash Flow Per Share | -1.13 | -0.19 | -1.64 | -1.73 | -2.99 | -5.67 | |
| Levered Free Cash Flow | -0.39 | 64.11 | -67.01 | -78.24 | -77.73 | -131.4 | |
| Unlevered Free Cash Flow | -0.39 | 64.11 | -67.01 | -78.24 | -77.73 | -131.4 | |
| Change in Net Working Capital | -74.91 | -88.72 | -8.75 | 24.54 | 4.81 | 25.99 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.